Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Prokineticin Receptor 1 Antikörper (N-Term)

PROKR1 Reaktivität: Human, Maus ELISA, WB, IHC, FACS Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN347055
  • Target Alle Prokineticin Receptor 1 (PROKR1) Antikörper anzeigen
    Prokineticin Receptor 1 (PROKR1)
    Bindungsspezifität
    • 8
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 27
    • 12
    • 12
    • 2
    • 2
    • 1
    Human, Maus
    Wirt
    • 26
    • 2
    Kaninchen
    Klonalität
    • 26
    • 2
    Polyklonal
    Konjugat
    • 17
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Prokineticin Receptor 1 Antikörper ist unkonjugiert
    Applikation
    • 10
    • 10
    • 5
    • 4
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    ELISA, Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS)
    Spezifität
    Reacts with human and mouse prokineticin receptor- 1
    Aufreinigung
    Antiserum
    Immunogen
    Synthetic peptide derived from N terminal region of human prokineticin receptor 1.
    Isotyp
    IgG
    Top Product
    Discover our top product PROKR1 Primärantikörper
  • Applikationshinweise

    Working dilution: Optimal dilution should be determined by the end user.
    The following are guidelines only :
    FC(1:100) IHC(1:100 - 1:1000) WB(1:200)

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Must be reconstituted in distilled water.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
    Haltbarkeit
    24 months
  • Brouillet, Murthi, Hoffmann, Salomon, Sergent, De Mazancourt, Dakouane-Giudicelli, Dieudonné, Rozenberg, Vaiman, Barbaux, Benharouga, Feige, Alfaidy: "EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR)." in: Cellular and molecular life sciences : CMLS, Vol. 70, Issue 3, pp. 511-25, (2013) (PubMed).

    Brouillet, Hoffmann, Chauvet, Salomon, Chamboredon, Sergent, Benharouga, Feige, Alfaidy: "Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors." in: Cellular and molecular life sciences : CMLS, Vol. 69, Issue 9, pp. 1537-50, (2012) (PubMed).

    Keramidas, Faudot, Cibiel, Feige, Thomas: "Mitogenic functions of endocrine gland-derived vascular endothelial growth factor and Bombina variegata 8 on steroidogenic adrenocortical cells." in: The Journal of endocrinology, Vol. 196, Issue 3, pp. 473-82, (2008) (PubMed).

    Hoffmann, Feige, Alfaidy: "Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation." in: Placenta, Vol. 28, Issue 10, pp. 1049-58, (2007) (PubMed).

  • Target
    Prokineticin Receptor 1 (PROKR1)
    Andere Bezeichnung
    Prokineticin Receptor 1 (PK-R1) (PROKR1 Produkte)
    Synonyme
    EG-VEGFR1 antikoerper, Gpr73 antikoerper, Pkr1 antikoerper, GPR73 antikoerper, GPR73a antikoerper, PKR1 antikoerper, ZAQ antikoerper, PROKR1 antikoerper, prokineticin receptor 1 antikoerper, Prokr1 antikoerper, PROKR1 antikoerper
    UniProt
    Q8TCW9
    Pathways
    Hedgehog Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma
Sie sind hier:
Kundenservice